Insignificant role of the N-terminal cobalt-binding site of albumin in the assessment of acute coronary syndrome: Discrepancy between the albumin cobalt-binding assay and N-terminal-targeted immunoassay

Biomarkers

Volumn 17, Issue 5, 2012, Pages 394-401

  Oh, Bum Jin ^a,b   Seo, Moon Hyeong ^a   Kim, Hak Sung ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Cobalt binding assay; Enzyme linked immunosorbent assay; Ischemia modified albumin; Myocardial ischemia

Indexed keywords

COBALT; HUMAN SERUM ALBUMIN; TROPONIN I;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ALBUMIN COBALT BINDING ASSAY; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING ASSAY; BINDING SITE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IN VIVO STUDY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; THORAX PAIN; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ADULT; AGED; AMINO ACID SEQUENCE; ANGINA, UNSTABLE; BINDING SITES; CHEST PAIN; COBALT; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PROTEIN BINDING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; TROPONIN I;

EID: 84864609845     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2012.672460     Document Type: Article

References (31)

1. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr, Jacobs AK, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine. (2007). ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committ e to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): Developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116:e148-e304.
2. Antman EM, Grudzien C, Sacks DB. (1995). Evaluation of a rapidbedside assay for detection of serum cardiac troponin T. JAMA 273:1279-1282.
3. Bar-Or D, Lau E, Winkler JV. (2000). A novel assay for cobalt-Albumin binding and its potential as a marker for myocardial ischemia-A preliminary report. J Emerg Med 19:311-315.
4. Bar-Or D, Rael LT, Bar-Or R, Slone DS, Craun ML. (2006). The formation and rapid clearance of a truncated albumin species in a critically ill patient. Clin Chim Acta 365:346-349.
5. Bar-Or D, Rael LT, Bar-Or R, Slone DS, Mains CW, Rao NK, Curtis CG. (2008). The cobalt-Albumin binding assay: Insights into its mode of action. Clin Chim Acta 387:120-127.
6. Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW. (2001). Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: A preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 141:985-991.
7. Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, Honda SA, Rios CN, Sugiyama CE, Ha CE. (2003). Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 49:581-585.
8. Cho DK, Choi JO, Kim SH, Choi J, Rhee I, Ki CS, Lee SC, Gwon HC. (2007). Ischemia-modified albumin is a highly sensitive serum marker of transient myocardial ischemia induced by coronary vasospasm. Coron Artery Dis 18:83-87.
9. Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P, Branham E, Apple FS, Murakami M, Morris DL. (2001). Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: A multicenter study. Clin Chem 47:464-470.
10. Dominguez-Rodriguez A, Abreu-Gonzalez P. (2010). Current role of ischemia-modified albumin in routine clinical practice. Biomarkers 15:655-662.
11. Dominguez-Rodriguez A, Abreu-Gonzalez P, Jimenez-Sosa A, Samimi- Fard S, Idaira HB. (2009). Does ischemia-modified albumin add prognostic value to the Thrombolysis In Myocardial Infarction risk score in patients with ST-segment elevation myocardial infarction treated with primary angioplasty Biomarkers 14:43-48.
12. Duarte MM, Rocha JB, Moresco RN, Duarte T, Da Cruz IB, Loro VL, Schetinger MR. (2009). Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem 42:666-671.
13. Hjortshoj S, Kristensen SR, Ravkilde J. (2010). Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome. Am J Emerg Med 28:170-176.
14. Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M, Katus H. (2000). It's time for a change to a troponin standard. Circulation 102:1216-1220.
15. Kazanis K, Dalamaga M, Nounopoulos C, Manolis AS, Sakellaris N, Jullien G, Dionyssiou-Asteriou A. (2009). Ischemia modified albumin, high-sensitivity c-reactive protein and natriuretic peptide in patients with coronary atherosclerosis. Clin Chim Acta 408:65-69.
16. Keating L, Benger JR, Beetham R, Bateman S, Veysey S, Kendall J, Pullinger R. (2006). The PRIMA study: Presentation ischaemia-modified albumin in the emergency department. Emerg Med J 23:764-768.
17. Kim JS, Hwang HJ, Ko YG, Choi D, Ha JW, Hong MK, Jang Y. (2010). Ischemia-modified albumin: Is it a reliable diagnostic and prognostic marker for myocardial ischemia in real clinical practice Cardiology 116:123-129.
18. Lippi G, Montagnana M, Salvagno GL, Guidi GC. (2007). Standardization of ischemia-modified albumin testing: Adjustment for serum albumin. Clin Chem Lab Med 45:261-262.
19. Morrow DA, de Lemos JA, Sabatine MS, Antman EM. (2003). The search for a biomarker of cardiac ischemia. Clin Chem 49:537-539.
20. Mothes E, Faller P. (2007). Evidence that the principal CoII-binding site in human serum albumin is not at the N-terminus: Implication on the albumin cobalt binding test for detecting myocardial ischemia. Biochemistry 46:2267-2274.
21. Peacock F, Morris DL, Anwaruddin S, Christenson RH, Collinson PO, Goodacre SW, Januzzi JL, Jesse RL, Kaski JC, Kontos MC, Lefevre G, Mutrie D, Sinha MK, Uettwiller-Geiger D, Pollack CV. (2006). Meta-Analysis of ischemia-modified lbumin to rule out acute coronary syndromes in the emergency department. Am Heart J 152:253-262.
22. Piwowar A, Knapik-Kordecka M, Warwas M. (2008). Ischemiamodified albumin level in type 2 diabetes mellitus - Preliminary report. Dis Markers 24:311-317.
23. Puleo PR, Meyer D, Wathen C, Tawa CB, Wheeler S, Hamburg RJ, Ali N, Obermueller SD, Triana JF, Zimmerman JL. (1994). Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N Engl J Med 331: 561-566.
24. Reiter M, Twerenbold R, Reichlin T, Haaf P, Peter F, Meissner J, Hochholzer W, Stelzig C, Freese M, Heinisch C, Breidthardt T, Freidank H, Winkler K, Campodarve I, Gea J, Mueller C. (2011). Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur. Heart J 32: 1379-1389.
25. Rioufol G, Finet G, Ginon I, André-Fouët X, Rossi R, Vialle E, Desjoyaux E, Convert G, Huret JF, Tabib A. (2002). Multiple atherosclerotic plaque rupture in acute coronary syndrome: A three-vessel intravascular ultrasound study. Circulation 106:804-808.
26. Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R, Gaze D, Collinson P, Carlos Kaski J. (2004). Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 97:297-301.
27. Sbarouni E, Georgiadou P, Theodorakis GN, Kremastinos DT. (2006). Ischemia-modified albumin in relation to exercise stress testing. J Am Coll Cardiol 48:2482-2484.
28. Sbarouni E, Georgiadou P, Voudris V. (2011). Gender-specific differences in biomarkers responses to acute coronary syndromes and revascularization procedures. Biomarkers 16:457-465.
29. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. (2004). Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 21:29-34.
30. Sokolowska M, Wszelaka-Rylik M, Poznanski J, Bal W. (2009). Spectroscopic and thermodynamic determination of three distinct binding sites for Co(II) ions in human serum albumin. J Inorg Biochem 103:1005-1013.
31. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. (2007). Universal definition of myocardial infarction. Eur. Heart J 28:2525-2538.